Publication Results

Generate Report

Add publications by marking their checkboxes, or

Periodontal pathogens are a risk factor of oral cavity squamous cell carcinoma, independent of tobacco and alcohol and human papillomavirus.

Ganly I,  Yang L,  Giese RA,  Hao Y,  Nossa CW,  Morris LGT,  Rosenthal M,  Migliacci J,  Kelly D,  Tseng W,  Hu J,  Li H,  Brown S,  Pei Z
Int J Cancer 2019 Aug 1;145(3):775-784
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 30671943
PMC ID: PMC6554043 [available on August 01, 2020]

Prostate Cancer Incidence and Mortality in Relationship to Family History of Prostate Cancer; Findings From The PLCO Trial.

Abdel-Rahman O
Clin Genitourin Cancer 2019 Aug;17(4):e837-e844
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 31213414
PMC ID: not available

Impact of Timeliness of Surgical Treatment on the Outcomes of Patients with Non-metastatic Non-small Cell Lung Cancer: Findings From the PLCO Trial.

Abdel-Rahman O
World J Surg 2019 Jul 22
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 31332492
PMC ID: not available

Dairy Product Consumption and Prostate Cancer Risk in the United States.

Preble I,  Zhang Z,  Kopp R,  Garzotto M,  Bobe G,  Shannon J,  Takata Y
Nutrients 2019 Jul 16;11(7)
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 31315238
PMC ID: not available

Deep Learning to Assess Long-term Mortality From Chest Radiographs.

Lu MT,  Ivanov A,  Mayrhofer T,  Hosny A,  Aerts HJWL,  Hoffmann U
JAMA Netw Open 2019 Jul 3;2(7):e197416
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 31322692
PMC ID: not available

Prediagnostic circulating markers of inflammation and risk of oesophageal adenocarcinoma: a study within the National Cancer Institute Cohort Consortium.

Cook MB,  Barnett MJ,  Bock CH,  Cross AJ,  Goodman PJ,  Goodman GE,  Haiman CA,  Khaw KT,  McCullough ML,  Newton CC,  Boutron-Ruault MC,  Lund E,  RutegÃ¥rd M,  Thornquist MD,  Spriggs M,  Giffen C,  Freedman ND,  Kemp T,  Kroenke CH,  Le Marchand L,  Park JY,  Simon M,  Wilkens LR,  Pinto L,  Hildesheim A,  Campbell PT
Gut 2019 Jun;68(6):960-968
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 30121626
PMC ID: PMC6379150 [available on June 01, 2020]

MGS-Fast: Metagenomic shotgun data fast annotation using microbial gene catalogs.

Brown SM,  Chen H,  Hao Y,  Laungani BP,  Ali TA,  Dong C,  Lijeron C,  Kim B,  Wultsch C,  Pei Z,  Krampis K
Gigascience 2019 Apr 1;8(4)
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 30942867
PMC ID: PMC6446249

Outcomes of Prostatectomy versus Radiation Therapy in the Management of Clinically Localized Prostate Cancer Patients Within the PLCO Trial.

Abdel-Rahman O
Clin Genitourin Cancer 2019 Apr;17(2):e329-e338
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 30704795
PMC ID: not available

Vitamin K intake and prostate cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer (PLCO) Screening Trial.

Hoyt M,  Reger M,  Marley A,  Fan H,  Liu Z,  Zhang J
Am J Clin Nutr 2019 Feb 1;109(2):392-401
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 30624568
PMC ID: not available

Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: long-term follow-up of the randomised US PLCO cancer screening trial.

Miller EA,  Pinsky PF,  Schoen RE,  Prorok PC,  Church TR
Lancet Gastroenterol Hepatol 2019 Feb;4(2):101-110
Major Program(s) or Research Group(s): Early Detection ;  Office of the Director ;  Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 30502933
PMC ID: PMC6335177 [available on February 01, 2020]

Associations Between Prediagnostic Concentrations of Circulating Sex Steroid Hormones and Esophageal/Gastric Cardia Adenocarcinoma Among Men.

Petrick JL,  Hyland PL,  Caron P,  Falk RT,  Pfeiffer RM,  Dawsey SM,  Abnet CC,  Taylor PR,  Weinstein SJ,  Albanes D,  Freedman ND,  Gapstur SM,  Bradwin G,  Guillemette C,  Campbell PT,  Cook MB
J Natl Cancer Inst 2019 Jan 1;111(1):34-41
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 29788475
PMC ID: PMC6335110

Serologic Response to Helicobacter pylori Proteins Associated With Risk of Colorectal Cancer Among Diverse Populations in the United States.

Butt J,  Varga MG,  Blot WJ,  Teras L,  Visvanathan K,  Le Marchand L,  Haiman C,  Chen Y,  Bao Y,  Sesso HD,  Wassertheil-Smoller S,  Ho GYF,  Tinker LE,  Peek RM,  Potter JD,  Cover TL,  Hendrix LH,  Huang LC,  Hyslop T,  Um C,  Grodstein F,  Song M,  Zeleniuch-Jacquotte A,  Berndt S,  Hildesheim A,  Waterboer T,  Pawlita M,  Epplein M
Gastroenterology 2019 Jan;156(1):175-186.e2
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 30296434
PMC ID: PMC6309494 [available on January 01, 2020]

Discovery of common and rare genetic risk variants for colorectal cancer.

Huyghe JR,  Bien SA,  Harrison TA,  Kang HM,  Chen S,  Schmit SL,  Conti DV,  Qu C,  Jeon J,  Edlund CK,  Greenside P,  Wainberg M,  Schumacher FR,  Smith JD,  Levine DM,  Nelson SC,  Sinnott-Armstrong NA,  Albanes D,  Alonso MH,  Anderson K,  Arnau-Collell C,  Arndt V,  Bamia C,  Banbury BL,  Baron JA,  Berndt SI,  Bézieau S,  Bishop DT,  Boehm J,  Boeing H,  Brenner H,  Brezina S,  Buch S,  Buchanan DD,  Burnett-Hartman A,  Butterbach K,  Caan BJ,  Campbell PT,  Carlson CS,  Castellví-Bel S,  Chan AT,  Chang-Claude J,  Chanock SJ,  Chirlaque MD,  Cho SH,  Connolly CM,  Cross AJ,  Cuk K,  Curtis KR,  de la Chapelle A,  Doheny KF,  Duggan D,  Easton DF,  Elias SG,  Elliott F,  English DR,  Feskens EJM,  Figueiredo JC,  Fischer R,  FitzGerald LM,  Forman D,  Gala M,  Gallinger S,  Gauderman WJ,  Giles GG,  Gillanders E,  Gong J,  Goodman PJ,  Grady WM,  Grove JS,  Gsur A,  Gunter MJ,  Haile RW,  Hampe J,  Hampel H,  Harlid S,  Hayes RB,  Hofer P,  Hoffmeister M,  Hopper JL,  Hsu WL,  Huang WY,  Hudson TJ,  Hunter DJ,  Ibañez-Sanz G,  Idos GE,  Ingersoll R,  Jackson RD,  Jacobs EJ,  Jenkins MA,  Joshi AD,  Joshu CE,  Keku TO,  Key TJ,  Kim HR,  Kobayashi E,  Kolonel LN,  Kooperberg C,  Kühn T,  Küry S,  Kweon SS,  Larsson SC,  Laurie CA,  Le Marchand L,  Leal SM,  Lee SC,  Lejbkowicz F,  Lemire M,  Li CI,  Li L,  Lieb W,  Lin Y,  Lindblom A,  Lindor NM,  Ling H,  Louie TL,  Männistö S,  Markowitz SD,  Martín V,  Masala G,  McNeil CE,  Melas M,  Milne RL,  Moreno L,  Murphy N,  Myte R,  Naccarati A,  Newcomb PA,  Offit K,  Ogino S,  Onland-Moret NC,  Pardini B,  Parfrey PS,  Pearlman R,  Perduca V,  Pharoah PDP,  Pinchev M,  Platz EA,  Prentice RL,  Pugh E,  Raskin L,  Rennert G,  Rennert HS,  Riboli E,  Rodríguez-Barranco M,  Romm J,  Sakoda LC,  Schafmayer C,  Schoen RE,  Seminara D,  Shah M,  Shelford T,  Shin MH,  Shulman K,  Sieri S,  Slattery ML,  Southey MC,  Stadler ZK,  Stegmaier C,  Su YR,  Tangen CM,  Thibodeau SN,  Thomas DC,  Thomas SS,  Toland AE,  Trichopoulou A,  Ulrich CM,  Van Den Berg DJ,  van Duijnhoven FJB,  Van Guelpen B,  van Kranen H,  Vijai J,  Visvanathan K,  Vodicka P,  Vodickova L,  Vymetalkova V,  Weigl K,  Weinstein SJ,  White E,  Win AK,  Wolf CR,  Wolk A,  Woods MO,  Wu AH,  Zaidi SH,  Zanke BW,  Zhang Q,  Zheng W,  Scacheri PC,  Potter JD,  Bassik MC,  Kundaje A,  Casey G,  Moreno V,  Abecasis GR,  Nickerson DA,  Gruber SB,  Hsu L,  Peters U
Nat Genet 2019 Jan;51(1):76-87
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 30510241
PMC ID: PMC6358437

The influence of obesity-related factors in the etiology of renal cell carcinoma-A mendelian randomization study.

Johansson M,  Carreras-Torres R,  Scelo G,  Purdue MP,  Mariosa D,  Muller DC,  Timpson NJ,  Haycock PC,  Brown KM,  Wang Z,  Ye Y,  Hofmann JN,  Foll M,  Gaborieau V,  Machiela MJ,  Colli LM,  Li P,  Garnier JG,  Blanche H,  Boland A,  Burdette L,  Prokhortchouk E,  Skryabin KG,  Yeager M,  Radojevic-Skodric S,  Ognjanovic S,  Foretova L,  Holcatova I,  Janout V,  Mates D,  Mukeriya A,  Rascu S,  Zaridze D,  Bencko V,  Cybulski C,  Fabianova E,  Jinga V,  Lissowska J,  Lubinski J,  Navratilova M,  Rudnai P,  Benhamou S,  Cancel-Tassin G,  Cussenot O,  Weiderpass E,  Ljungberg B,  Tumkur Sitaram R,  Häggström C,  Bruinsma F,  Jordan SJ,  Severi G,  Winship I,  Hveem K,  Vatten LJ,  Fletcher T,  Larsson SC,  Wolk A,  Banks RE,  Selby PJ,  Easton DF,  Andreotti G,  Beane Freeman LE,  Koutros S,  Männistö S,  Weinstein S,  Clark PE,  Edwards TL,  Lipworth L,  Gapstur SM,  Stevens VL,  Carol H,  Freedman ML,  Pomerantz MM,  Cho E,  Wilson KM,  Gaziano JM,  Sesso HD,  Freedman ND,  Parker AS,  Eckel-Passow JE,  Huang WY,  Kahnoski RJ,  Lane BR,  Noyes SL,  Petillo D,  Teh BT,  Peters U,  White E,  Anderson GL,  Johnson L,  Luo J,  Buring J,  Lee IM,  Chow WH,  Moore LE,  Eisen T,  Henrion M,  Larkin J,  Barman P,  Leibovich BC,  Choueiri TK,  Lathrop GM,  Deleuze JF,  Gunter M,  McKay JD,  Wu X,  Houlston RS,  Chanock SJ,  Relton C,  Richards JB,  Martin RM,  Davey Smith G,  Brennan P
PLoS Med 2019 Jan;16(1):e1002724
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 30605491
PMC ID: PMC6317776

Differential effects of depot medroxyprogesterone acetate administration on vaginal microbiome in Hispanic White and Black women.

Yang L,  Hao Y,  Hu J,  Kelly D,  Li H,  Brown S,  Tasker C,  Roche NE,  Chang TL,  Pei Z
Emerg Microbes Infect 2019;8(1):197-210
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 30866773
PMC ID: PMC6455113

AA9int: SNP interaction pattern search using non-hierarchical additive model set.

Lin HY,  Huang PY,  Chen DT,  Tung HY,  Sellers TA,  Pow-Sang JM,  Eeles R,  Easton D,  Kote-Jarai Z,  Amin Al Olama A,  Benlloch S,  Muir K,  Giles GG,  Wiklund F,  Gronberg H,  Haiman CA,  Schleutker J,  Nordestgaard BG,  Travis RC,  Hamdy F,  Neal DE,  Pashayan N,  Khaw KT,  Stanford JL,  Blot WJ,  Thibodeau SN,  Maier C,  Kibel AS,  Cybulski C,  Cannon-Albright L,  Brenner H,  Kaneva R,  Batra J,  Teixeira MR,  Pandha H,  Lu YJ,  PRACTICAL Consortium,  Park JY
Bioinformatics 2018 Dec 15;34(24):4141-4150
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 29878078
PMC ID: PMC6289141 [available on December 15, 2019]

Circulating cotinine concentrations and lung cancer risk in the Lung Cancer Cohort Consortium (LC3).

Larose TL,  Guida F,  Fanidi A,  Langhammer A,  Kveem K,  Stevens VL,  Jacobs EJ,  Smith-Warner SA,  Giovannucci E,  Albanes D,  Weinstein SJ,  Freedman ND,  Prentice R,  Pettinger M,  Thomson CA,  Cai Q,  Wu J,  Blot WJ,  Arslan AA,  Zeleniuch-Jacquotte A,  Le Marchand L,  Wilkens LR,  Haiman CA,  Zhang X,  Stampfer MJ,  Hodge AM,  Giles GG,  Severi G,  Johansson M,  Grankvist K,  Wang R,  Yuan JM,  Gao YT,  Koh WP,  Shu XO,  Zheng W,  Xiang YB,  Li H,  Lan Q,  Visvanathan K,  Hoffman Bolton J,  Ueland PM,  Midttun Ø,  Caporaso N,  Purdue M,  Sesso HD,  Buring JE,  Lee IM,  Gaziano JM,  Manjer J,  Brunnström H,  Brennan P,  Johansson M
Int J Epidemiol 2018 Dec 1;47(6):1760-1771
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 29901778
PMC ID: PMC6280953 [available on December 01, 2019]

Genetic variant of IRAK2 in the toll-like receptor signaling pathway and survival of non-small cell lung cancer.

Xu Y,  Liu H,  Liu S,  Wang Y,  Xie J,  Stinchcombe TE,  Su L,  Zhang R,  Christiani DC,  Li W,  Wei Q
Int J Cancer 2018 Nov 15;143(10):2400-2408
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 29978465
PMC ID: PMC6205899 [available on November 15, 2019]

Two high-risk susceptibility loci at 6p25.3 and 14q32.13 for Waldenström macroglobulinemia.

McMaster ML,  Berndt SI,  Zhang J,  Slager SL,  Li SA,  Vajdic CM,  Smedby KE,  Yan H,  Birmann BM,  Brown EE,  Smith A,  Kleinstern G,  Fansler MM,  Mayr C,  Zhu B,  Chung CC,  Park JH,  Burdette L,  Hicks BD,  Hutchinson A,  Teras LR,  Adami HO,  Bracci PM,  McKay J,  Monnereau A,  Link BK,  Vermeulen RCH,  Ansell SM,  Maria A,  Diver WR,  Melbye M,  Ojesina AI,  Kraft P,  Boffetta P,  Clavel J,  Giovannucci E,  Besson CM,  Canzian F,  Travis RC,  Vineis P,  Weiderpass E,  Montalvan R,  Wang Z,  Yeager M,  Becker N,  Benavente Y,  Brennan P,  Foretova L,  Maynadie M,  Nieters A,  de Sanjose S,  Staines A,  Conde L,  Riby J,  Glimelius B,  Hjalgrim H,  Pradhan N,  Feldman AL,  Novak AJ,  Lawrence C,  Bassig BA,  Lan Q,  Zheng T,  North KE,  Tinker LF,  Cozen W,  Severson RK,  Hofmann JN,  Zhang Y,  Jackson RD,  Morton LM,  Purdue MP,  Chatterjee N,  Offit K,  Cerhan JR,  Chanock SJ,  Rothman N,  Vijai J,  Goldin LR,  Skibola CF,  Caporaso NE
Nat Commun 2018 Oct 10;9(1):4182
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 30305637
PMC ID: PMC6180091

Oral Alpha, Beta, and Gamma HPV Types and Risk of Incident Esophageal Cancer.

Agalliu I,  Chen Z,  Wang T,  Hayes RB,  Freedman ND,  Gapstur SM,  Burk RD
Cancer Epidemiol Biomarkers Prev 2018 Oct;27(10):1168-1175
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 30087123
PMC ID: PMC6170688 [available on October 01, 2019]

The relationship between diabetes, prostate-specific antigen screening tests, and prostate cancer.

Miller EA,  Pinsky PF,  Pierre-Victor D
Cancer Causes Control 2018 Oct;29(10):907-914
Major Program(s) or Research Group(s): Cancer Prevention Fellowship ProgramEarly DetectionProstate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 30094676
PMC ID: not available

Number of Adenomas Removed and Colorectal Cancers Prevented in Randomized Trials of Flexible Sigmoidoscopy Screening.

Pinsky PF,  Loberg M,  Senore C,  Wooldrage K,  Atkin W,  Bretthauer M,  Cross AJ,  Hoff G,  Holme O,  Kalager M,  Segnan N,  Schoen RE
Gastroenterology 2018 Oct;155(4):1059-1068.e2
Major Program(s) or Research Group(s): Early DetectionProstate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 29935150
PMC ID: not available

Concentrated sugars and incidence of prostate cancer in a prospective cohort.

Miles FL,  Neuhouser ML,  Zhang ZF
Br J Nutr 2018 Sep;120(6):703-710
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 30047347
PMC ID: PMC6123266

55-year-old man with ulcers in inguinal fold and intergluteal cleft found to have systemic Langerhans cell histiocytosis.

Mu EW,  Khurram NA,  Pei Z,  Feng H,  Cassai N,  Meehan SA,  Latkowski JA
JAAD Case Rep 2018 Sep;4(8):837-840
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 30238052
PMC ID: PMC6143693

A dietary pattern based on estrogen metabolism is associated with breast cancer risk in a prospective cohort of postmenopausal women.

Guinter MA,  McLain AC,  Merchant AT,  Sandler DP,  Steck SE
Int J Cancer 2018 Aug 1;143(3):580-590
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 29574860
PMC ID: PMC6019153

An estrogen-related lifestyle score is associated with risk of postmenopausal breast cancer in the PLCO cohort.

Guinter MA,  McLain AC,  Merchant AT,  Sandler DP,  Steck SE
Breast Cancer Res Treat 2018 Aug;170(3):613-622
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 29651647
PMC ID: PMC6026043

Secondary prostate cancer screening outcomes by race in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Screening Trial.

Miller EA,  Pinsky PF,  Black A,  Andriole GL,  Pierre-Victor D
Prostate 2018 Aug;78(11):830-838
Major Program(s) or Research Group(s): Cancer Prevention Fellowship ProgramEarly DetectionProstate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 29667217
PMC ID: not available

Biology and Clinical Implications of the 19q13 Aggressive Prostate Cancer Susceptibility Locus.

Gao P,  Xia JH,  Sipeky C,  Dong XM,  Zhang Q,  Yang Y,  Zhang P,  Cruz SP,  Zhang K,  Zhu J,  Lee HM,  Suleman S,  Giannareas N,  Liu S,  PRACTICAL Consortium,  Tammela TLJ,  Auvinen A,  Wang X,  Huang Q,  Wang L,  Manninen A,  Vaarala MH,  Wang L,  Schleutker J,  Wei GH
Cell 2018 Jul 26;174(3):576-589.e18
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 30033361
PMC ID: PMC6091222

Modifiable risk factors to reduce renal cell carcinoma incidence: Insight from the PLCO trial.

Gelfond J,  Al-Bayati O,  Kabra A,  Iffrig K,  Kaushik D,  Liss MA
Urol Oncol 2018 Jul;36(7):340.e1-340.e6
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 29779672
PMC ID: not available

Association of Coffee and Tea Intake with the Oral Microbiome: Results from a Large Cross-Sectional Study.

Peters BA,  McCullough ML,  Purdue MP,  Freedman ND,  Um CY,  Gapstur SM,  Hayes RB,  Ahn J
Cancer Epidemiol Biomarkers Prev 2018 Jul;27(7):814-821
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 29703763
PMC ID: not available

Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.

Schumacher FR,  Al Olama AA,  Berndt SI,  Benlloch S,  Ahmed M,  Saunders EJ,  Dadaev T,  Leongamornlert D,  Anokian E,  Cieza-Borrella C,  Goh C,  Brook MN,  Sheng X,  Fachal L,  Dennis J,  Tyrer J,  Muir K,  Lophatananon A,  Stevens VL,  Gapstur SM,  Carter BD,  Tangen CM,  Goodman PJ,  Thompson IM Jr,  Batra J,  Chambers S,  Moya L,  Clements J,  Horvath L,  Tilley W,  Risbridger GP,  Gronberg H,  Aly M,  Nordström T,  Pharoah P,  Pashayan N,  Schleutker J,  Tammela TLJ,  Sipeky C,  Auvinen A,  Albanes D,  Weinstein S,  Wolk A,  HÃ¥kansson N,  West CML,  Dunning AM,  Burnet N,  Mucci LA,  Giovannucci E,  Andriole GL,  Cussenot O,  Cancel-Tassin G,  Koutros S,  Beane Freeman LE,  Sorensen KD,  Orntoft TF,  Borre M,  Maehle L,  Grindedal EM,  Neal DE,  Donovan JL,  Hamdy FC,  Martin RM,  Travis RC,  Key TJ,  Hamilton RJ,  Fleshner NE,  Finelli A,  Ingles SA,  Stern MC,  Rosenstein BS,  Kerns SL,  Ostrer H,  Lu YJ,  Zhang HW,  Feng N,  Mao X,  Guo X,  Wang G,  Sun Z,  Giles GG,  Southey MC,  MacInnis RJ,  FitzGerald LM,  Kibel AS,  Drake BF,  Vega A,  Gómez-Caamaño A,  Szulkin R,  Eklund M,  Kogevinas M,  Llorca J,  Castaño-Vinyals G,  Penney KL,  Stampfer M,  Park JY,  Sellers TA,  Lin HY,  Stanford JL,  Cybulski C,  Wokolorczyk D,  Lubinski J,  Ostrander EA,  Geybels MS,  Nordestgaard BG,  Nielsen SF,  Weischer M,  Bisbjerg R,  Røder MA,  Iversen P,  Brenner H,  Cuk K,  Holleczek B,  Maier C,  Luedeke M,  Schnoeller T,  Kim J,  Logothetis CJ,  John EM,  Teixeira MR,  Paulo P,  Cardoso M,  Neuhausen SL,  Steele L,  Ding YC,  De Ruyck K,  De Meerleer G,  Ost P,  Razack A,  Lim J,  Teo SH,  Lin DW,  Newcomb LF,  Lessel D,  Gamulin M,  Kulis T,  Kaneva R,  Usmani N,  Singhal S,  Slavov C,  Mitev V,  Parliament M,  Claessens F,  Joniau S,  Van den Broeck T,  Larkin S,  Townsend PA,  Aukim-Hastie C,  Gago-Dominguez M,  Castelao JE,  Martinez ME,  Roobol MJ,  Jenster G,  van Schaik RHN,  Menegaux F,  Truong T,  Koudou YA,  Xu J,  Khaw KT,  Cannon-Albright L,  Pandha H,  Michael A,  Thibodeau SN,  McDonnell SK,  Schaid DJ,  Lindstrom S,  Turman C,  Ma J,  Hunter DJ,  Riboli E,  Siddiq A,  Canzian F,  Kolonel LN,  Le Marchand L,  Hoover RN,  Machiela MJ,  Cui Z,  Kraft P,  Amos CI,  Conti DV,  Easton DF,  Wiklund F,  Chanock SJ,  Henderson BE,  Kote-Jarai Z,  Haiman CA,  Eeles RA,  Profile Study,  Australian Prostate Cancer BioResource (APCB),  IMPACT Study,  Canary PASS Investigators,  Breast and Prostate Cancer Cohort Consortium (BPC3),  PRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome) Consortium,  Cancer of the Prostate in Sweden (CAPS),  Prostate Cancer Genome-wide Association Study of Uncommon Susceptibility Loci (PEGASUS),  Genetic Associations and Mechanisms in Oncology (GAME-ON)/Elucidating Loci Involved in Prostate Cancer Susceptibility (ELLIPSE) Consortium
Nat Genet 2018 Jul;50(7):928-936
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 29892016
PMC ID: PMC6568012

Body mass index (BMI) trajectories and risk of colorectal cancer in the PLCO cohort.

Zheng R,  Du M,  Zhang B,  Xin J,  Chu H,  Ni M,  Zhang Z,  Gu D,  Wang M
Br J Cancer 2018 Jul;119(1):130-132
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 29872147
PMC ID: PMC6035226

A taxonomic signature of obesity in a large study of American adults.

Peters BA,  Shapiro JA,  Church TR,  Miller G,  Trinh-Shevrin C,  Yuen E,  Friedlander C,  Hayes RB,  Ahn J
Sci Rep 2018 Jun 27;8(1):9749
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 29950689
PMC ID: PMC6021409

HPViewer: sensitive and specific genotyping of human papillomavirus in metagenomic DNA.

Hao Y,  Yang L,  Galvao Neto A,  Amin MR,  Kelly D,  Brown SM,  Branski RC,  Pei Z
Bioinformatics 2018 Jun 15;34(12):1986-1995
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 29377990
PMC ID: not available

Inflammatory potential of diet and risk of pancreatic cancer in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.

Zheng J,  Merchant AT,  Wirth MD,  Zhang J,  Antwi SO,  Shoaibi A,  Shivappa N,  Stolzenberg-Solomon RZ,  Hebert JR,  Steck SE
Int J Cancer 2018 Jun 15;142(12):2461-2470
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 29355939
PMC ID: PMC5908732

Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants.

Dadaev T,  Saunders EJ,  Newcombe PJ,  Anokian E,  Leongamornlert DA,  Brook MN,  Cieza-Borrella C,  Mijuskovic M,  Wakerell S,  Olama AAA,  Schumacher FR,  Berndt SI,  Benlloch S,  Ahmed M,  Goh C,  Sheng X,  Zhang Z,  Muir K,  Govindasami K,  Lophatananon A,  Stevens VL,  Gapstur SM,  Carter BD,  Tangen CM,  Goodman P,  Thompson IM Jr,  Batra J,  Chambers S,  Moya L,  Clements J,  Horvath L,  Tilley W,  Risbridger G,  Gronberg H,  Aly M,  Nordström T,  Pharoah P,  Pashayan N,  Schleutker J,  Tammela TLJ,  Sipeky C,  Auvinen A,  Albanes D,  Weinstein S,  Wolk A,  Hakansson N,  West C,  Dunning AM,  Burnet N,  Mucci L,  Giovannucci E,  Andriole G,  Cussenot O,  Cancel-Tassin G,  Koutros S,  Freeman LEB,  Sorensen KD,  Orntoft TF,  Borre M,  Maehle L,  Grindedal EM,  Neal DE,  Donovan JL,  Hamdy FC,  Martin RM,  Travis RC,  Key TJ,  Hamilton RJ,  Fleshner NE,  Finelli A,  Ingles SA,  Stern MC,  Rosenstein B,  Kerns S,  Ostrer H,  Lu YJ,  Zhang HW,  Feng N,  Mao X,  Guo X,  Wang G,  Sun Z,  Giles GG,  Southey MC,  MacInnis RJ,  FitzGerald LM,  Kibel AS,  Drake BF,  Vega A,  Gómez-Caamaño A,  Fachal L,  Szulkin R,  Eklund M,  Kogevinas M,  Llorca J,  Castaño-Vinyals G,  Penney KL,  Stampfer M,  Park JY,  Sellers TA,  Lin HY,  Stanford JL,  Cybulski C,  Wokolorczyk D,  Lubinski J,  Ostrander EA,  Geybels MS,  Nordestgaard BG,  Nielsen SF,  Weisher M,  Bisbjerg R,  Røder MA,  Iversen P,  Brenner H,  Cuk K,  Holleczek B,  Maier C,  Luedeke M,  Schnoeller T,  Kim J,  Logothetis CJ,  John EM,  Teixeira MR,  Paulo P,  Cardoso M,  Neuhausen SL,  Steele L,  Ding YC,  De Ruyck K,  De Meerleer G,  Ost P,  Razack A,  Lim J,  Teo SH,  Lin DW,  Newcomb LF,  Lessel D,  Gamulin M,  Kulis T,  Kaneva R,  Usmani N,  Slavov C,  Mitev V,  Parliament M,  Singhal S,  Claessens F,  Joniau S,  Van den Broeck T,  Larkin S,  Townsend PA,  Aukim-Hastie C,  Gago-Dominguez M,  Castelao JE,  Martinez ME,  Roobol MJ,  Jenster G,  van Schaik RHN,  Menegaux F,  Truong T,  Koudou YA,  Xu J,  Khaw KT,  Cannon-Albright L,  Pandha H,  Michael A,  Kierzek A,  Thibodeau SN,  McDonnell SK,  Schaid DJ,  Lindstrom S,  Turman C,  Ma J,  Hunter DJ,  Riboli E,  Siddiq A,  Canzian F,  Kolonel LN,  Le Marchand L,  Hoover RN,  Machiela MJ,  Kraft P,  PRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome) Consortium,  Freedman M,  Wiklund F,  Chanock S,  Henderson BE,  Easton DF,  Haiman CA,  Eeles RA,  Conti DV,  Kote-Jarai Z
Nat Commun 2018 Jun 11;9(1):2256
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 29892050
PMC ID: PMC5995836

Using Metabolomics to Explore the Role of Postmenopausal Adiposity in Breast Cancer Risk.

Lasky-Su JA,  Zeleznik OA,  Eliassen AH
J Natl Cancer Inst 2018 Jun 1;110(6):547-548
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 29325156
PMC ID: PMC6279286

A Metabolomics Analysis of Body Mass Index and Postmenopausal Breast Cancer Risk.

Moore SC,  Playdon MC,  Sampson JN,  Hoover RN,  Trabert B,  Matthews CE,  Ziegler RG
J Natl Cancer Inst 2018 Jun 1;110(6):588-597
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 29325144
PMC ID: PMC6279273

Determining Risk of Colorectal Cancer and Starting Age of Screening Based on Lifestyle, Environmental, and Genetic Factors.

Jeon J,  Du M,  Schoen RE,  Hoffmeister M,  Newcomb PA,  Berndt SI,  Caan B,  Campbell PT,  Chan AT,  Chang-Claude J,  Giles GG,  Gong J,  Harrison TA,  Huyghe JR,  Jacobs EJ,  Li L,  Lin Y,  Le Marchand L,  Potter JD,  Qu C,  Bien SA,  Zubair N,  Macinnis RJ,  Buchanan DD,  Hopper JL,  Cao Y,  Nishihara R,  Rennert G,  Slattery ML,  Thomas DC,  Woods MO,  Prentice RL,  Gruber SB,  Zheng Y,  Brenner H,  Hayes RB,  White E,  Peters U,  Hsu L,  Colorectal Transdisciplinary Study and Genetics and Epidemiology of Colorectal Cancer Consortium
Gastroenterology 2018 Jun;154(8):2152-2164.e19
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 29458155
PMC ID: PMC5985207

Association of Colonoscopy Adenoma Findings With Long-term Colorectal Cancer Incidence.

Click B,  Pinsky PF,  Hickey T,  Doroudi M,  Schoen RE
JAMA 2018 May 15;319(19):2021-2031
Major Program(s) or Research Group(s): Cancer Prevention Fellowship ProgramEarly DetectionProstate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 29800214
PMC ID: PMC6583246

Drinking alcohol is associated with variation in the human oral microbiome in a large study of American adults.

Fan X,  Peters BA,  Jacobs EJ,  Gapstur SM,  Purdue MP,  Freedman ND,  Alekseyenko AV,  Wu J,  Yang L,  Pei Z,  Hayes RB,  Ahn J
Microbiome 2018 Apr 24;6(1):59
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 29685174
PMC ID: PMC5914044

Genome-wide association study identifies susceptibility loci for B-cell childhood acute lymphoblastic leukemia.

Vijayakrishnan J,  Studd J,  Broderick P,  Kinnersley B,  Holroyd A,  Law PJ,  Kumar R,  Allan JM,  Harrison CJ,  Moorman AV,  Vora A,  Roman E,  Rachakonda S,  Kinsey SE,  Sheridan E,  Thompson PD,  Irving JA,  Koehler R,  Hoffmann P,  Nöthen MM,  Heilmann-Heimbach S,  Jöckel KH,  Easton DF,  Pharaoh PDP,  Dunning AM,  Peto J,  Canzian F,  Swerdlow A,  Eeles RA,  Kote-Jarai Z,  Muir K,  Pashayan N,  PRACTICAL Consortium,  Greaves M,  Zimmerman M,  Bartram CR,  Schrappe M,  Stanulla M,  Hemminki K,  Houlston RS
Nat Commun 2018 Apr 9;9(1):1340
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 29632299
PMC ID: PMC5890276

Use of Digital Rectal Examination as an Adjunct to Prostate Specific Antigen in the Detection of Clinically Significant Prostate Cancer.

Halpern JA,  Oromendia C,  Shoag JE,  Mittal S,  Cosiano MF,  Ballman KV,  Vickers AJ,  Hu JC
J Urol 2018 Apr;199(4):947-953
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 29061540
PMC ID: not available

Height, selected genetic markers and prostate cancer risk: results from the PRACTICAL consortium.

Lophatananon A,  Stewart-Brown S,  Kote-Jarai Z,  Al Olama AA,  Garcia SB,  Neal DE,  Hamdy FC,  Donovan JL,  Giles GG,  Fitzgerald LM,  Southey MC,  Pharoah P,  Pashayan N,  Gronberg H,  Wiklund F,  Aly M,  Stanford JL,  Brenner H,  Dieffenbach AK,  Arndt V,  Park JY,  Lin HY,  Sellers T,  Slavov C,  Kaneva R,  Mitev V,  Batra J,  Spurdle A,  Clements JA,  APCB BioResource,  PRACTICAL consortium,  Easton D,  Eeles RA,  Muir K
Br J Cancer 2018 Mar 20;118(6):e16
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 29438364
PMC ID: PMC5877441

A comprehensive analysis of polymorphic variants in steroid hormone and insulin-like growth factor-1 metabolism and risk of in situ breast cancer: Results from the Breast and Prostate Cancer Cohort Consortium.

Barrdahl M,  Canzian F,  Gaudet MM,  Gapstur SM,  Trichopoulou A,  Tsilidis K,  van Gils CH,  Borgquist S,  Weiderpass E,  Khaw KT,  Giles GG,  Milne RL,  Le Marchand L,  Haiman C,  Lindström S,  Kraft P,  Hunter DJ,  Ziegler R,  Chanock SJ,  Yang XR,  Buring JE,  Lee IM,  Kaaks R,  Campa D
Int J Cancer 2018 Mar 15;142(6):1182-1188
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 29114882
PMC ID: not available

The efficacy of prostate-specific antigen screening: Impact of key components in the ERSPC and PLCO trials.

de Koning HJ,  Gulati R,  Moss SM,  Hugosson J,  Pinsky PF,  Berg CD,  Auvinen A,  Andriole GL,  Roobol MJ,  Crawford ED,  Nelen V,  Kwiatkowski M,  Zappa M,  Luján M,  Villers A,  de Carvalho TM,  Feuer EJ,  Tsodikov A,  Mariotto AB,  Heijnsdijk EAM,  Etzioni R
Cancer 2018 Mar 15;124(6):1197-1206
Major Program(s) or Research Group(s): Early DetectionProstate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 29211316
PMC ID: PMC5839977

Family History of Cancer and Risk of Biliary Tract Cancers: Results from the Biliary Tract Cancers Pooling Project.

Van Dyke AL,  Langhamer MS,  Zhu B,  Pfeiffer RM,  Albanes D,  Andreotti G,  Beane Freeman LE,  Chan AT,  Freedman ND,  Gapstur SM,  Giles GG,  Grodstein F,  Liao LM,  Luo J,  Milne RL,  Monroe KR,  Neuhouser ML,  Poynter JN,  Purdue MP,  Robien K,  Schairer C,  Sinha R,  Weinstein S,  Zhang X,  Petrick JL,  McGlynn KA,  Campbell PT,  Koshiol J
Cancer Epidemiol Biomarkers Prev 2018 Mar;27(3):348-351
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 29339358
PMC ID: PMC5835211

Dietary intake of isoflavones and coumestrol and the risk of prostate cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.

Reger MK,  Zollinger TW,  Liu Z,  Jones JF,  Zhang J
Int J Cancer 2018 Feb 15;142(4):719-728
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 29114854
PMC ID: not available

Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts.

Seibert TM,  Fan CC,  Wang Y,  Zuber V,  Karunamuni R,  Parsons JK,  Eeles RA,  Easton DF,  Kote-Jarai Z,  Al Olama AA,  Garcia SB,  Muir K,  Grönberg H,  Wiklund F,  Aly M,  Schleutker J,  Sipeky C,  Tammela TL,  Nordestgaard BG,  Nielsen SF,  Weischer M,  Bisbjerg R,  Røder MA,  Iversen P,  Key TJ,  Travis RC,  Neal DE,  Donovan JL,  Hamdy FC,  Pharoah P,  Pashayan N,  Khaw KT,  Maier C,  Vogel W,  Luedeke M,  Herkommer K,  Kibel AS,  Cybulski C,  Wokolorczyk D,  Kluzniak W,  Cannon-Albright L,  Brenner H,  Cuk K,  Saum KU,  Park JY,  Sellers TA,  Slavov C,  Kaneva R,  Mitev V,  Batra J,  Clements JA,  Spurdle A,  Teixeira MR,  Paulo P,  Maia S,  Pandha H,  Michael A,  Kierzek A,  Karow DS,  Mills IG,  Andreassen OA,  Dale AM,  PRACTICAL Consortium*
BMJ 2018 Jan 10;360:j5757
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 29321194
PMC ID: PMC5759091

Circulating Folate, Vitamin B6, and Methionine in Relation to Lung Cancer Risk in the Lung Cancer Cohort Consortium (LC3).

Fanidi A,  Muller DC,  Yuan JM,  Stevens VL,  Weinstein SJ,  Albanes D,  Prentice R,  Thomsen CA,  Pettinger M,  Cai Q,  Blot WJ,  Wu J,  Arslan AA,  Zeleniuch-Jacquotte A,  McCullough ML,  Le Marchand L,  Wilkens LR,  Haiman CA,  Zhang X,  Han J,  Stampfer MJ,  Smith-Warner SA,  Giovannucci E,  Giles GG,  Hodge AM,  Severi G,  Johansson M,  Grankvist K,  Langhammer A,  Krokstad S,  Næss M,  Wang R,  Gao YT,  Butler LM,  Koh WP,  Shu XO,  Xiang YB,  Li H,  Zheng W,  Lan Q,  Visvanathan K,  Bolton JH,  Ueland PM,  Midttun Ø,  Ulvik A,  Caporaso NE,  Purdue M,  Ziegler RG,  Freedman ND,  Buring JE,  Lee IM,  Sesso HD,  Gaziano JM,  Manjer J,  Ericson U,  Relton C,  Brennan P,  Johansson M
J Natl Cancer Inst 2018 Jan 1;110(1)
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 28922778
PMC ID: PMC5989622